Search Results

You are looking at 21 - 25 of 25 items for :

  • "Capecitabine" x
  • Refine by Access: All Content x
Clear All
Orvosi Hetilap
Authors: Alexandra Bartal, Zoltán Mátrai, Attila Szűcs, Galina Belinszkaja, Zoltán Langmár, and András Rosta

Geyer, C. E., Forster, J., Lindquist, D., et al.: Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N. Engl. J. Med., 2006, 355 , 2733–2743. Lindquist D

Open access
Orvosi Hetilap
Authors: István Láng, Zsuzsanna Kahán, Erika Hitre, Magdolna Dank, Gábor Rubovszky, Zsolt Horváth, and Miklós Kásler

., et al.: Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J. Clin. Oncol., 2002, 20 , 2812

Open access

capecitabine in patients with pretreated metastatic breast cancer . Cancer Chemother Pharmacol 65 : 871 – 876 , 2010 . 41. Schmid P Krocker

Restricted access

capecitabine in patients with pretreated metastatic breast cancer Cancer Chemother Pharmacol 65 871 – 876 . 41 Schmid , P , Krocker , J , Jehn , C et al. 2005 Primary chemotherapy with

Restricted access

sorafenib in combination with capecitabine in patients with hepatocellular carcinoma: INST 08-20 . Oncologist 22 , 1158 – 1160 . 10.1634/theoncologist.2017-0168 Peng , L

Restricted access